Hyponidd

### Composition:

Hyponidd typically contains the following active ingredients:

• **Glibenclamide (Glyburide)**: An oral hypoglycemic agent that helps lower blood sugar levels.
• **Metformin**: A biguanide that improves insulin sensitivity and decreases hepatic glucose production.

### Dosage:

The dosage of Hyponidd can vary based on individual patient needs, but a common regimen may include:

• **Initial Dose**: 1 tablet taken orally, usually with meals.
• **Maintenance Dose**: The dose may be adjusted based on blood glucose levels, typically ranging from 1 to 2 tablets per day.
• **Maximum Dose**: Do not exceed the prescribed maximum dose as determined by a healthcare provider.

### Indications:

Hyponidd is indicated for:

• The management of type 2 diabetes mellitus in adults, particularly in patients who are not adequately controlled on diet and exercise alone.
• It may be used in combination with other antidiabetic medications when necessary.

### Important Considerations:

• Monitor blood glucose levels regularly while on Hyponidd.
• Adjustments may be necessary based on renal function and other health conditions.
• Patients should be aware of potential side effects, including gastrointestinal disturbances, hypoglycemia, and allergic reactions.

Always consult a healthcare professional for personalized medical advice and before starting any new medication.